1. Phillips B, Young T, Finn L, Asher K, Hening WA, Purvis C. Epidemiology of restless legs symptoms in adults. Arch Intern Med 2000;160:2137–2141. PMID:
10904456.
2. Oka Y, Ioue Y. Secondary restless legs syndrome. Brain Nerve 2009;61:539–547. PMID:
19514514.
3. Kang SG, Lee HJ, Jung SW, Cho SN, Han C, Kim YK, et al. Characteristics and clinical correlates of restless legs syndrome in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2007;31:1078–1083. PMID:
17459547.
4. Aggarwal S, Dodd S, Berk M. Restless leg syndrome associated with atypical antipsychotics: current status, pathophysiology, and clinical implications. Curr Drug Saf 2015;10:98–105. PMID:
24861990.
5. Winkelman JW, Plante DT. Foundations of Psychiatric Sleep Medicine. New York: Cambridge University Press, Cambridge; 2010.
6. Pichler I, Marroni F, Volpato CB, Gusella JF, Klein C, Casari G, et al. Linkage analysis identifies a novel locus for restless legs syndrome on chromosome 2q in a South Tyrolean population isolate. Am J Hum Genet 2006;79:716–723. PMID:
16960808.
7. Chen S, Ondo WG, Rao S, Li L, Chen Q, Wang Q. Genomewide linkage scan identifies a novel susceptibility locus for RLS on chromosome 9p. Am J Hum Genet 2004;74:876–885. PMID:
15077200.
8. Desautels A, Turecki G, Montplaisir J, Xiong L, Walters AS, Ehrenberg BL, et al. Restless legs syndrome: confirmation of linkage to chromosome 12q, genetic heterogeneity, and evidence of complexity. Arch Neurol 2005;62:591–596. PMID:
15824258.
9. Levchenko A, Montplaisir JY, Dube MP, Riviere JB, St-Onge J, Turecki G, et al. The 14q restless legs syndrome locus in the French Canadian population. Ann Neurol 2004;55:887–891. PMID:
15174026.
10. Kemlink D, Plazzi G, Vetrugno R, Provini F, Polo O, Stiasny-Kolster K, et al. Suggestive evidence for linkage for restless legs syndrome on chromosome 19p13. Neurogenetics 2008;9:75–82. PMID:
18193462.
11. Levchenko A, Provost S, Montplaisir JY, Xiong L, St-Onge J, Thibodeau P, et al. A novel autosomal dominant restless legs syndrome locus maps to chromosome 20p13. Neurology 2006;67:900–901. PMID:
16966564.
12. Levchenko A, Montplaisir JY, Asselin G, Provost S, Girard SL, Xiong L, et al. Autosomal-dominant locus for Restless Legs Syndrome in French-Canadians on chromosome 16p12.1. Mov Disord 2009;24:40–50. PMID:
18946881.
13. Stefansson H, Rye DB, Hicks A, Petursson H, Ingason A, Thorgeirsson TE, et al. A genetic risk factor for periodic limb movements in sleep. N Engl J Med 2007;357:639–647. PMID:
17634447.
14. Winkelmann J, Schormair B, Lichtner P, Ripke S, Xiong L, Jalilzadeh S, et al. Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions. Nat Genet 2007;39:1000–1006. PMID:
17637780.
15. Kang SG, Lee HJ, Choi JE, Park JH, Lee SS, Han C, et al. Possible association between G-protein β3 subunit C825T polymorphism and antipsychotic-induced restless legs syndrome in schizophrenia. Acta Neuropsychiatr 2007;19:351–356. PMID:
26953000.
16. Kang SG, Lee HJ, Choi JE, Park YM, Park JH, Han C, et al. Association study between antipsychotics-induced restless legs syndrome and polymorphisms of dopamine D1, D2, D3, and D4 receptor genes in schizophrenia. Neuropsychobiology 2008;57:49–54. PMID:
18451638.
17. Kang SG, Park YM, Choi JE, Lim SW, Lee HJ, Lee SH, et al. Association study between antipsychotic-induced restless legs syndrome and polymorphisms of monoamine oxidase genes in schizophrenia. Hum Psychopharmacol 2010;25:397–403. PMID:
20589923.
19. Kang SG, Lee HJ, Park YM, Yang HJ, Song HM, Lee YJ, et al. The BTBD9 gene may be associated with antipsychotic-induced restless legs syndrome in schizophrenia. Hum Psychopharmacol 2013;28:117–123. PMID:
23361623.
20. Jung JS, Lee HJ, Cho CH, Kang SG, Yoon HK, Park YM, et al. Association between restless legs syndrome and CLOCK and NPAS2 gene polymorphisms in schizophrenia. Chronobiol Int 2014;31:838–844. PMID:
24824748.
22. Han OS, Hong JP. Structured Clinical Interview for DSM-IV Axis I Disorder-Korean Version. Seoul: Hana Medical Publishing; 2000.
23. American Psychiatric Association. Practice Guidelines for the Treatment of Patients with Schizophrenia. Washington, DC: American Psychiatric Press; 1997.
24. Bazire S. Psychotropic Drug Directory. The Professionals' Pocket Handbook and Aide Memoire. Salisbury, UK: Fivepin; 2005.
25. Hales RE, Yudofski SC. Textbook of Clinical Psychiatry. Fourth Ed. Washington, DC: American Psychiatric Publishing; 2002.
26. Inagaki A, Inada T, Fujii Y, Yagi G, Yoshio T, Nakamura H, et al. Dose Equivalence of Psychotic Drugs. Tokyo: Seiwa Press; 1999.
27. Woods SW. Chlorpromazine equivalent doses for the newer atypical antipsychotics. J Clin Psychiatry 2003;64:663–667. PMID:
12823080.
28. Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisi J. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless leg syndrome diagnosis and epidemiology workshop at the National Institute of Health. Sleep Med 2003;4:101–119. PMID:
14592341.
29. Walters AS, LeBrocq C, Dhar A, Hening W, Rosen R, Allen RP, et al. Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med 2003;4:121–132. PMID:
14592342.
30. Barnes TR. A rating scale for drug-induced akathisia. Br J Psychiatry 1989;672–676. PMID:
2574607.
31. Lin CH, Chen ML, Wu VC, Li WY, Sy HN, Wu SL, et al. Association of candidate genetic variants with restless legs syndrome in end stage renal disease: a multicenter case-control study in Taiwan. Eur J Neurol 2014;21:492–498. PMID:
24433515.
32. Klingaman EA, Palmer-Bacon J, Bennett ME, Rowland LM. Sleep disorders among people with schizophrenia: emerging research. Curr Psychiatry Rep 2015;17:79PMID:
26279058.
33. Kemlink D, Polo O, Frauscher B, Gschliesser V, Hogl B, Poewe W, et al. Replication of restless legs syndrome loci in three European populations. J Med Genet 2009;46:315–318. PMID:
19279021.
34. Moore H 4th, Winkelmann J, Lin L, Finn L, Peppard P. Periodic leg movements during sleep are associated with polymorphisms in BTBD9, TOX3/BC034767, MEIS1, MAP2K5/SKOR1, and PTPRD. Sleep 2014;37:1535–1542. PMID:
25142570.
35. Yang Q, Li L, Chen Q, Foldvary-Schaefer N, Ondo WG, Wang QK. Association studies of variants in MEIS1, BTBD9, and MAP2K5/SKOR1 with restless legs syndrome in a US population. Sleep Med 2011;12:800–804. PMID:
21925394.
36. Zhou G, Bao ZQ, Dixon JE. Components of a new human protein kinase signal transduction pathway. J Biol Chem 1995;270:12665–12669. PMID:
7759517.
37. Dinev D, Jordan BW, Neufeld B, Lee JD, Lindemann D, Rapp UR, et al. Extracellular signal regulated kinase 5 (ERK5) is required for the differentiation of muscle cells. EMBO Rep 2001;2:829–834. PMID:
11520859.
38. Cavanaugh JE, Jaumotte JD, Lakoski JM, Zigmond MJ. Neuroprotective role of ERK1/2 and ERK5 in a dopaminergic cell line under basal conditions and in response to oxidative stress. J Neurosci Res 2006;84:1367–1375. PMID:
16941494.
39. Hening WA. Current guidelines and standards of practice for restless legs syndrome. Am J Med 2007;120(1 Suppl 1):S22–S27. PMID:
17198767.
40. Mignot E. A step forward for restless legs syndrome. Nat Genet 2007;39:938–939. PMID:
17660808.
41. Winkelmann J, Czamara D, Schormair B, Knauf F, Schulte EC, Trenkwalder C, et al. Genome-wide association study identifies novel restless legs syndrome susceptibility loci on 2p14 and 16q12.1. PLoS Genet 2011;7:e1002171. PMID:
21779176.
42. Vilarino-Guell C, Farrer MJ, Lin SC. A genetic risk factor for periodic limb movements in sleep. N Engl J Med 2008;358:425–427. PMID:
18216367.
43. Kim MK, Cho YW, Shin WC, Cho JW, Shon YM, Kim JH, et al. Association of restless legs syndrome variants in Korean patients with restless legs syndrome. Sleep 2013;36:1787–1791. PMID:
24293752.